No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects

European Journal of Clinical Investigation

Volumn 27, Issue 7, 1997, Pages 629-633

  Fliser, D ^a   Stefanski, A ^a   Franek, E ^a   Fode, P ^a   Gudarzi, A ^a   Ritz, E ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Calcitriol; Euglycaemic clamp; Insulin sensitivity; Intracellular calcium; Parathyroid hormone

Indexed keywords

CALCITRIOL; CALCIUM ION; GLUCOSE; INSULIN; PARATHYROID HORMONE;

ADULT; ARTICLE; CALCIUM CELL LEVEL; CALCIUM URINE LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HUMAN EXPERIMENT; INSULIN SENSITIVITY; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030860090     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.1520699.x     Document Type: Article

References (28)

1. Amend WJC, Steinberg SM, Lowrie EG et al. The influence of calcium and parathyroid hormone upon glucose metabolism in uraemia. J Lab Clin Med 1975;86:435-44.
2. DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in uremia. J Clin Invest 1981;67:563-72.
3. Akmal M, Massry SG, Goldstein DA, Fanti P, Weisz A, DeFronzo RA. Role of parathyroid hormone in the glucose intolerance of chronic renal failure. J Clin Invest 1985;75:1037-44.
4. Alvestrand A, Mujagic M, Wajngt A, Efendic S. Glucose intolerance in uremic patients: the relative contributions of impaired-cell function and insulin resistance. Clin Nephrol 1989; 31:175-83.
5. Mak RHK, DeFronzo RA. Glucose and insulin metabolism in uremia. Nephron 1992;61:377-82.
6. Fliser D, Rett C, Hübinger A, Ritz E. Influence of ACE inhibition on glucose tolerance in patients with stable chronic renal failure. Nephrol Dial Transplant 1995;10:643-7.
7. Fadda GZ, Akmal M, Lipson LG, Massry SG. Direct effect of parathyroid hormone on insulin secretion from pancreatic cells. Am J Physiol 1990;258:E975-84.
8. Kautzky-Willer A, Pacini G, Barnas U et al. Intravenous calcitriol normalizes insulin sensitivity in uremic patients. Kidney Int 1995; 47:200-6.
9. Mak RHK. Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int 1992;41: 1049-54.
10. Mak RHK. Amelioration of hypertension and insulin resistance by 1,25-dihydroxycholecalciferol in hemodialysis patients. Pediatr Nephrol 1992;6:345-8.
11. Türk S, Yeksan M, Tamer N, Gürbilek M, Erdogan Y, Erkul I. Effect of 1,25 (OH)2D3 treatment on glucose intolerance in uraemia. Nephrol Dial Transplant 1992;7:1207-12.
12. Levi E, Fadda GZ, Thanakitcharu P, Massry SG. Chronology of cellular events leading to derangements in function of pancreatic islets in chronic renal failure. J Am Soc Nephrol 1992;3:1139-46.
13. Mak RHK, Bertinelli A, Turner C, Haycock B, Chantler C. The influence of hyperparathyroidism on glucose metabolism in uremia. J Clin Endocrinol Metab 1985;60:229-33.
14. Graf H, Prager R, Kovarik J, Lugar A, Schernthaner G, Pinggera WF. Glucose metabolism and sensitivity in patients on chronic hemodialysis. Metabolism 1985;34:974-7.
15. Lu KC, Shieh SD, Lin SH et al. Hyperparathyroidism, glucose tolerance and platelet intracellular free calcium in chronic renal failure. Q J Med 1994;87:359-65.
16. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-23.
17. Blind E, Schmidt-Gayk H, Armbruster FP, Stadler A. Measurement of intact human parathyrin by an extracting two-site immunoradiometric assay. Clin Chem 1987;33:1376-81.
18. + indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-50.
19. Lind L, Pollare T, Hvarfner A, Lithell H, Sorensen OH, Ljunghall S. Long-term treatment with active vitamin D (alphacalcidol) in middle aged men with impaired glucose tolerance. Effects on insulin secretion and sensitivity, glucose tolerance and blood pressure. Diabetes Res 1989;11:141-7.
20. Lind L, Wengle B, Lithell H, Ljunghall S. Plasma ionized calcium and cardiovascular risk factors in mild primary hyperparathyroidism: effects of long-term treatment with active vitamin D (alphacalcidol). J Intern Med 1992;231:427-32.
21. Rodriguez M, Felsenfeld AJ, Williams C, Pederson JA, Llach F. The effects of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients. J Am Soc Nephrol 1991;2:1914-20.
22. Slatopolsky E, Weets C, Thielan J, Horst R, Harter H, Martin KJ. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest 1984;74:2136-43.
23. Levy J, Gavin JR. Diabetes mellitus: a disease of abnormal cellular calcium metabolism. Am J Med 1994;96:260-73.
24. Tschoepe D, Rosen P, Gries FA. Increase in the cytosolic concentration of calcium in platelets of type 2 diabetics. Thromb Res 1991;62:421-8.
25. + antiport in the development of hypertension and insulin resistance. J Am Soc Nephrol 1992;3:1049-63.
26. Plehwe WE, Williams PF, Caterson ID, Harrison LC, Turtle JR. Calcium-dependence of insulin receptor phosphorylation. Biochem J 1983;214:361-6.
27. Moore RD. Effects of insulin upon ion transport. Biochim Biophys Acta 1983;737:1-49.
28. Draznin B, Sussman K, Kao M, Leweis D, Sherman N. The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes. J Biol Chem 1987;262:14385-8.